Australia: Food and Drugs Law

Australia's pharmaceutical patent landscape has reached a critical juncture, with appellate courts reconsidering fundamental principles of patent scope, term extensions, and remedies that will shape originator-generic disputes for the foreseeable future. As the High Court prepares to rule on patent term extensions for formulation patents and new Federal Court practice directions take effect, the strategic calculus for both innovators and generic entrants is being fundamentally rewritten.

FTI Consulting's unique combination of financial expertise and practical farming knowledge positions the firm to build trust between investors and operators.

The legal status of ayahuasca and potential criminal consequences if you were to use it.